NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Feasibility of Using NeuraSignal Transcranial Doppler Robot
Feasibility of Using NeuraSignal Transcranial Doppler Robot

NCT06565442

Not Yet RecruitingN/A

Sponsor: University of Alabama at Birmingham

Conditions: Cerebral Autoregulation

Interventions: NeuraSignal transcranial doppler robot

Countries: United States

The purpose of this study is to determine the feasibility of using the NeuraSignal transcranial doppler robot in a neuro ICU setting to measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves

Eligibility overview

Sex: ALL

Age: 18 Years to 89 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* 18-89
* Patients admitted to the Neuro ICU for blood pressure management (MAP management) after spinal surgery

Exclusion Criteria:

* Patients under 18 years (or bodyweight \<50kg if age unknown),
* prisoners
* pregnant women,
* non-English speaking,
* patients enrolled in concurrent
* ongoing interventional trial
* students of UAB
* employees of UAB
* targeting specific populations
* patients with previously diagnosed brain pathology
* patients with open wounds over temporal bones precluding transcranial doppler
Locations (1)
  • Birmingham, Alabama, United States